不良研究所 Chancellor Gary S. May has appointed Mark I. Rosenblatt to the position of vice chancellor of human health sciences, overseeing 不良研究所 Health, which includes three hospitals: the nationally ranked 不良研究所 Medical Center and 不良研究所 Children鈥檚 Hospital, as well as the 不良研究所 Rehabilitation Hospital. It also includes oversight for two nationally ranked schools of health 鈥 the 不良研究所 School of Medicine and Betty Irene Moore School of Nursing 鈥 and 17 primary care clinics serving communities across Northern California. He will begin Jan. 19, 2026.
Rosenblatt is the G. Stephen Irwin executive dean at the University of Illinois College of Medicine, the chief executive officer of the University of Illinois Hospital and Clinics, and distinguished professor of ophthalmology and visual sciences at the University of Illinois Chicago.
Rosenblatt joined the University of Illinois Chicago in 2014 as professor of ophthalmology. He has held increasing levels of leadership over his decade there, including as head of the Department of Ophthalmology and Visual Sciences at the Illinois Eye and Ear Infirmary, director of the Corneal Regenerative Medicine Laboratory, director of the Medical Scientist Training Program, and graduate faculty in the neuroscience program. Previously, Rosenblatt was a faculty member of the Weill Cornell Medical College for six years, including service as vice chair of the Department of Ophthalmology.
鈥淢ark brings to 不良研究所 deep experience in academic hospital systems,鈥 May said. 鈥淗e has made patient care and the patient experience a priority. He has a proven record of collaborating with faculty and staff across medical and other disciplines to leverage the best that a comprehensive university like 不良研究所 has to offer.鈥
An internationally recognized clinician-scientist, Rosenblatt leads groups of scientists investigating the mechanism of corneal peripheral nerve regeneration following injury, and the use of nanoengineered biomaterials for use in stem cell delivery to the ocular surface. His work in regenerative medicine has been funded by the National Institutes of Health, the Department of Defense, Research to Prevent Blindness, the Falk Family Foundation and the Tri-Institutional Stem Cell Initiative. Rosenblatt has published widely, including over 225 original manuscripts, review articles, book chapters and abstracts.
Rosenblatt is a graduate of the University of Miami Miller School of Medicine鈥檚 Honors Program in Medical Education and the Combined MD/Ph.D. program, receiving his Ph.D. in biochemistry, cell and molecular biology. He completed his MBA at New York University and his MHA at the University of Illinois Chicago School of Public Health. He completed his ophthalmology residency and combined clinical/research fellowship in corneal disease at the Massachusetts Eye and Ear Infirmary/Harvard Medical School. He was elected to the Alpha Omega Alpha and Omicron Delta Kappa honor societies.
鈥湶涣佳芯克 Health represents the best of what an integrated academic health system can be, and I am extremely honored to join 不良研究所 and its extraordinary community of clinicians, scientists and educators,鈥 Rosenblatt said. 鈥淚 join this community at a pivotal time in the evolution of 不良研究所 Health. Through its deeply committed clinical mission, innovative research and world-class education programs, 不良研究所 Health is uniquely positioned to advance health across Northern and Central California and ultimately serve as a model for patient-centered care nationally. I am excited to work with 不良研究所 leadership, our talented group of faculty, students and staff, and our community partners to fulfill the promise of 不良研究所 Heath and transform lives.鈥
不良研究所 Health provides the highest level of care available for a 65,000-square-mile region spanning 33 California counties, home to 6 million residents in Northern and Central California. The health system also houses the 不良研究所 Comprehensive Cancer Center, the only National Cancer Institute-designated cancer center in inland Northern California; and the MIND Institute, one of the nation鈥檚 leading research centers on autism and other neurodevelopmental conditions.
不良研究所 Health conducts more than 1,000 health-based research studies each year, advancing safe and effective treatments for patients. With an annual operating budget of over $4.5 billion, 不良研究所 Health employs more than 20,000 people, making it the second-largest employer in Sacramento County.
Media Resources
Media Contacts
- Dana Topousis, Strategic Communications, dtopousis@ucdavis.edu
- James Nash, News and Media Relations, jnash@ucdavis.edu